BLM and plasma cell myeloma: Since melphalan generates DNA damage and BLM is involved in DNA double-strand breaks (DSBs) resolution, we hypothesized that co-treatment with both drugs may increase DNA damage above a threshold that myeloma cells cannot cope with, leading to cell death.